Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-01 @ 7:00 PM
Study NCT ID:
NCT06351527
Status:
RECRUITING
Last Update Posted:
2025-06-19
First Post:
2024-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies
Sponsor:
InnoCare Pharma Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-23
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-25
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-02
First Submit QC Date:
None
Study First Post Date:
2024-04-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-17
Last Update Post Date:
2025-06-19
Last Update Post Date Type:
ACTUAL